Skip to content

Author

Camilla Medeiros Froese Buzogany

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Rimegepant for migraine prophylaxis: a systematic review and meta-analysis of randomized controlled trials

Background: Migraine is a leading cause of global disability, often requiring effective preventive strategies to reduce disease burden and improve patient quality of life. Rimegepant is an oral small-molecule calcitonin gene-related peptide (CGRP) receptor antagonist. Although its efficacy in the acute treatment of mig...

Larah Cerqueira Alves, Raquel Mattos Filgueiras, V. Vidal et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.